Skip to main content
Skip to main content

AAP Gateway

Advanced Search »

User menu

  • Login
  • Current Policy
  • Topic/Program Collections
  • Submit Manuscript
  • Alerts
  • Subscribe
  • aap.org

Menu

  • AAP Grand Rounds
  • AAP News
  • Hospital Pediatrics
  • NeoReviews
  • Pediatrics
  • Pediatrics in Review
  • Current AAP Policy
  • Journal CME
  • AAP Career Center
  • Pediatric Collections
  • AAP Journals Catalog

Sections

    • Login
    • Current Policy
    • Topic/Program Collections
    • Submit Manuscript
    • Alerts
    • Subscribe
    • aap.org

    Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care.

    New! Video Abstracts -- brief videos summarizing key findings of new articles

    Know what's next when you read AAP Journals, view the new 2018 Catalog.
    Trainees,
    enter the SOPT Essay Contest for a chance to be published in Pediatrics!

    Advertising Disclaimer »

    Tools and Links

    Pediatrics
    August 2001, VOLUME 108 / ISSUE 2
    From the American Academy of Pediatrics
    ELECTRONIC ARTICLE

    Chronic Oxygen Dependency in Infants Born at Less Than 32 Weeks' Gestation: Incidence and Risk Factors

    Laurent Egreteau, Jean-Yves Pauchard, Denis S. Semama, Jacqueline Matis, Anne Liska, Bernard Romeo, Fabrice Cneude, Isabelle Hamon, Patrick Truffert
    • Article
    • Figures & Data
    • Info & Metrics
    • Comments
    Loading
    Download PDF

    Abstract

    Objective. To assess incidence and clinical risk factors of chronic oxygen dependency (COD) among survivors who were born at or before 31 weeks' gestation.

    Methods. This prospective, multicenter study enrolled 802 infants who were born at or before 31 weeks' gestation and admitted to 8 level III neonatal intensive care units in northern and eastern France from January 1 through December 31, 1997. Need for oxygen to maintain oxygen saturation between 92% and 96% was assessed at 28 days of life and at 36 and 42 weeks' postconceptional age (PCA). Stepwise logistic regression analysis was used to identify the incidence of COD and the risk factors related to its occurrence.

    Results. The mortality rate was 14%. Antenatal corticotherapy was administered to 51% of patients, surfactant therapy to 76% of the ventilated patients, and high-frequency oscillatory ventilation at day 1 to 32%. At 28 days and 36 and 42 weeks' PCA, respectively, 25%, 15%, and 6% of survivors had COD. After adjustment for intercenter variations, we identified the significant risk factors for COD at these dates: a low gestational age, a high score on the Clinical Risk Index for Infants, intrauterine growth restriction, and surfactant treatment.

    Conclusion. COD incidence was high at 28 days of life but decreased dramatically by 42 weeks' PCA. This study confirmed previously reported risk factors and underlined the importance of intrauterine growth restriction and the Clinical Risk Index for Infants as significant risk factors.

    • bronchopulmonary dysplasia
    • chronic oxygen dependency

    Recent advances in perinatal care have improved the survival rates of very preterm infants. New therapies introduced during the past decade have reduced mortality, but their effectiveness in reducing the occurrence of bronchopulmonary dysplasia (BPD) remains controversial.1 BPD incidence varies in published studies from 4.6% to 72%.2,,3 This broad range may be explained by the heterogeneity of the studied populations, of management practices, or of disease definitions. The initial description of chronic oxygen dependency (COD) by Northway et al4 and later by Bancalari et al5 defined it according to oxygen requirements at 28 days of age. As newborns of lower gestational age (GA) survived, Shennan et al6 proposed a more open-ended approach to COD: chronic lung disease (CLD). CLD, defined as oxygen dependency at 36 weeks' postconceptional age (PCA), seemed to be a better marker of abnormal pulmonary outcome. Most studies about COD incidence have been either retrospective or performed in the presurfactant era.

    We conducted this prospective, multicenter study to learn more about COD today. Its purpose was to estimate the incidence and risk factors for COD, at various PCAs, in premature infants who are born at or before 31 weeks' gestation in the surfactant era.

    METHODS

    Eight level III neonatal intensive care units in northern and eastern France collaborated in a prospective study from January 1 to December 31, 1997. They all are located near sea level. The number of neonatal intensive care cots ranges from 6 to 16 among centers. All infants who were born at 31 weeks' GA or younger and admitted to participating units were enrolled.

    The following variables were studied: gender, GA (ascertained by fetal ultrasonography before 14 weeks' gestation or the date of the mother's last menstrual period), and birth weight. Antenatal history included such disorders as pregnancy-related hypertension or prolonged premature rupture of the membranes (for >24 hours), complete antenatal corticotherapy (2 doses at least 12 hours before delivery), mode of delivery (vaginal delivery, cesarean section before or during labor), and inborn status. The Clinical Risk Index for Infants (CRIB) score7 was calculated for each patient. Concerning outborn patients, data for CRIB score calculation were collected from outborn unit charts by the neonatal transfer team. For home deliveries, data were recorded continuously during transport. Respiratory data included need for surfactant therapy (Curosurf, Chiesi Pharmaceutical, Parma, Italy, or Exosurf, Burroughs Wellcome, Research Triangle Park, NC), modes of ventilation, and need for supplemental oxygen at 28 days of life and at 36 and 42 weeks' PCA. Oxygen therapy was defined as justified if needed to achieve an oxygen saturation between 92% and 96% during quiet sleep (Nellcor oximeter pulse N-200; Nellcor Inc, Haywood, CA). Neonatal infection was defined as clinical signs of illness associated with increased inflammatory markers and a positive culture of blood, urine, or tracheal samplings. Nosocomial infection was considered for clinical deterioration with a positive blood culture. We also recorded data about symptomatic treated patent ductus arteriosus (indomethacin or ligature), need for diuretic and corticosteroid therapy, intracerebral hemorrhage8 or leukomalacia, retinopathy of prematurity, and survival or death at discharge. The protocol did not impose any standard policies (eg, fluid intake, ventilation, indomethacin, corticosteroids) on the centers for treatment of these infants.

    Intrauterine growth restriction (IUGR) was defined according to Lucas charts.9 Incidence of COD was stratified by GA and by birth weight. GA was coded as bands because of small numbers in the youngest GA. Centers were coded as categorical data and monitored with the partial method. The center with the lowest incidence of COD was used as the reference group. CRIB scores were coded in 3 bands (0–5, 6–10, and 11–20) because of a small number of patients in the band 16 to 20.

    To assess the reliability of collected data, we listed different questions about the same item (eg, duration of oxygen supplementation and PCA at oxygen weaning). Moreover, in each center, an extra observer checked the validity of collected data for 5% of included infants.

    The association between recorded variables and COD was tested by univariate analysis. Variables were selected for logistic regression when they met the following criteria recommended by Greenland10: 1) P < .20, and 2) they had been observed previously to have effects on COD incidence in premature infants. Statistical significance was determined for categorical data by χ2 test or Fischer exact test when appropriate. Multivariate analysis was conducted by stepwise logistic regression (BMDP Software Inc, Los Angeles, CA).

    RESULTS

    This 12-month prospective, multicenter study enrolled 802 infants. None of them had any congenital malformations or chromosomal abnormalities. No one was subsequently excluded for missing data. Concerning validity of collected data, no major error was observed among the 5% controlled files.

    Distribution according to GA was as follows: 54 (7%) born at 23 to 25 weeks, 136 (17%) at 26 to 27 weeks, 259 (32%) at 28 to 29 weeks, and 353 (44%) at 30 to 31 weeks. Univariate analysis did not show any significant difference in the distribution of GA among centers.

    Table 1 shows demographic and obstetric characteristics of infants. Rate of antenatal steroid therapy was low (51%), with a range from 33% to 77% among the 8 centers. Sixty-eight percent of the newborns were inborn. Eight deliveries occurred at home. Rate of deliveries were 11%, 20%, and 68% in level 1, 2, and 3 units, respectively. Table 2 illustrates the initial severity of illness, assessed according to need for ventilation on first day of life, surfactant therapy in the first 24 hours of life, and CRIB score.

    View this table:
    • View inline
    • View popup
    Table 1.

    General Characteristics of Pregnancies and Infants

    View this table:
    • View inline
    • View popup
    Table 2.

    Initial Severity of Illness

    Mortality rate in the overall cohort was 14%. Figure 1 summarizes incidence of death and COD according to GA. Of 706 infants who survived to 28 days, 175 (25%) developed BPD, defined as requiring oxygen at that point. At 36 weeks' PCA, 106 (15%) of 695 survivors required oxygen; 18 of these were not oxygen dependent at 28 days of life. At 42 weeks' PCA, 41 infants (6%) were oxygen dependent; 39 were discharged from the hospital with oxygen.

    Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Mortality and chronic oxygen dependency according to GA at 28 days of life and 36, 42, and 48 weeks' PCA. For each band of GA, black bars indicate dead patients, shaded bars indicate survivors with COD, and open bars indicate survivors without COD.

    The incidence of COD at the different endpoints varied widely among the 8 centers (Table 3). Incidence at 28 days of life and 36 weeks' PCA, respectively, ranged from 9% and 2.5% for center A to 46% and 32% for center F. The centers did not differ significantly as to GA, pregnancy-related disorders, prenatal steroids, mode of delivery, or surfactant therapy.

    View this table:
    • View inline
    • View popup
    Table 3.

    Significant Risk Factors for Chronic Oxygen Dependence: Univariate Analysis

    The univariate analysis found the following risk factors for COD: center, low GA, IUGR, high CRIB score, surfactant treatment, treated patent ductus arteriosus, and grades 3 and 4 intraventricular hemorrhage (Table 3). Birth weight was significantly lower in every COD group: 966 ± 250 g versus 1301 ± 312, 915 ± 217 versus 1278 ± 316, and 933 ± 282 versus 1218 ± 325 at 28 days of life and 36 and 42 weeks' PCA, respectively.

    Table 4 shows the adjusted odds ratios obtained from the multiple regression analysis. At 36 weeks' PCA, the following factors were significantly predictive of COD: centers, low GA, IUGR, high CRIB score, and surfactant replacement therapy. As a high colinearity was observed among GA, IUGR, and birth weight, this last variable was not introduced in the multivariate model.

    View this table:
    • View inline
    • View popup
    Table 4.

    Significant Adjusted Odds Ratios for Chronic Oxygen Dependency (Odds Ratio [CI 95%])

    DISCUSSION

    To our knowledge, this is the first prospective, multicenter study to describe incidence and risk factors of COD in a cohort of very premature survivors in the surfactant era. The mortality rate of 14% is consistent with other published data.11,,12

    COD incidence varies widely in the published data.2,,313–15 Some of this difference can be explained by the various combinations of numerators and denominators used to compute this incidence. The denominator may be based on figures from the hospital,13 multiple center,14 or the general population.15 Unlike population-based data, our denominator does not include infants who were recorded as liveborn but who died before reaching the nursery. In the population-based study by Darlow et al,14 these newborns represented 12.5% of the very low birth weight population. As we expressed COD incidence among survivors, this difference does not affect the interpretation of our results.

    The standard for oxygen was the same in all 8 centers: an oxygen saturation between 92% and 96% during quiet sleep, with the same precalibrated oximeter. Differences in management (eg, fluid intake, ventilation settings, postnatal corticosteroids) might explain variations in the incidence of COD among centers. In an 8-center survey about BPD, Avery et al16 pointed out a similar degree of variability in nursery policies among centers, especially for respiratory care.

    After multiple regression analysis that adjusted for center, other risk factors remained important. The most significant was GA.

    Few studies have focused on populations defined by GA; they most often reported data stratified by birth weight. Fenton et al15reported BPD rates in a population-based study of 2 regions, Trent and British Columbia, in 1990 and 1991. BPD incidence in survivors of 32 weeks or less or of 750 to 1500 g was 16.3% and 24.5%, respectively. The CLD rate was 6.4% and 18.5%.

    Lenoir et al17 described the short- and mid-term outcome of 1157 neonates with respiratory distress syndrome (RDS), born during a 15-month period in 1990 to 1991. BPD occurred in 72% of the infants who were born before 26 weeks' GA, 50% at 26 to 27 weeks' GA, 28% at 28 to 29 weeks' GA, and 13% at 30 to 31 weeks' GA.

    In a recent 1-year prospective multicenter study, Rubaltelli et al18 enrolled 1048 infants who were born before 32 weeks' gestation. The infants were treated with surfactant and managed with oxygen, continuous positive airway pressure, and conventional ventilation. Incidence of BPD was low in every GA group: 10% for infants born at 23 to 25 weeks, 13% for those born at 26 to 27 weeks, 9% for those born at 28 to 29 weeks, and 2% for those born at 30 to 31 weeks. The author explained this lower incidence of BPD by a high rate of antenatal steroid treatment (71% of infants with respiratory disorders vs 51% in our study). This difference also might be explained by mortality: mortality data were not provided, and the BPD incidence was calculated with the entire population, rather than simply survivors, as the denominator.

    It seems to us that GA is a reliable predictor of COD. It is related to the morphologic and functional immaturity of the respiratory system, and this immaturity is one of the major determinants of COD in very preterm infants.

    We also found the CRIB score to be related to COD. As others have reported,7,,19 CRIB was correlated with the risk of death in our population, a finding indicating that the score was valid. Our results show that CRIB also is an accurate index of initial neonatal risk of COD at 28 days of life and at 36 and 42 weeks' PCA.

    CRIB initially was defined as “a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units” for infants with a birth weight of 1500 g or less or a GA younger than 31 weeks.19 In 1996, Fowlie et al20 reported that this scoring system also could contribute to more comprehensive predictive models of death and nosocomial bacteremia. More recently, these authors21 showed that throughout the first week of life, CRIB score was correlated with the risk of death, disability, and prolonged treatment with oxygen at 28 days and 36 weeks' PCA. Only 1% of the high-risk neonates included in Fowlie's study, however, were treated with surfactant replacement. Accordingly, it has been suggested that “this relationship may not be present in the surfactant era” and that “surfactant use has aged the CRIB score faster than other scores.”22 As surfactant replacement therapy has a minimal impact on BPD,23 we do not think that this conclusion necessarily follows. It certainly is not confirmed by the results of our multicenter prospective study in which 76% of the ventilated infants received surfactant.

    Moreover, our results are logically consistent, because 4 of the 6 variables considered in CRIB are confirmed BPD risk factors (low GA, birth weight, and minimum and maximum inspired fraction of oxygen in the first 12 hours of life, which can be considered as markers of severe RDS). Our findings thus demonstrate that CRIB is not yet at risk of being “washed away by clinical advance.”22 It remains an early and reliable score that helps to predict the occurrence and severity of COD in infants who are born at less than 32 weeks' gestation.

    IUGR, present in 25% of our population, also was a risk factor for COD. Distribution of IUGR was homogeneous among the 8 centers. Conflicting results in the early 1990s reported that IUGR was a protective factor24 or a risk factor for COD.17 More recently, Todd et al,13 using multivariate analysis, also reported a strong correlation between IUGR and COD at 36 weeks' PCA in a cohort of 1454 infants who were born at 24 to 32 weeks' gestation. These clinical results are supported by experimental data about malnutrition-induced adverse pulmonary effects during the perinatal period.25,,26

    Antenatal steroid therapy was not correlated with a lower incidence of COD in univariate analysis. We believe that the beneficial effects of antenatal steroid therapy on COD would have been demonstrated if the rate of treatment has been clearly higher.

    Incidence of surfactant therapy was 57% in the overall population but 76% of ventilated infants. This indicates an early therapeutic approach to RDS management and not a rescue strategy, which would have selected the most severe patients. The correlation between surfactant replacement and COD in our population suggests that surfactant therapy could not prevent RDS from developing into BPD. Two meta-analyses1,,27 failed to find that surfactant treatment, regardless of its type or mode, has any direct preventive effect on BPD that seems to be determined multifactorially and is not linked to RDS alone.

    It is unexpected that although inflammation is thought to be associated closely with CLD,28,,29 none of the relevant factors recorded in our study (premature rupture of membranes, neonatal or nosocomial sepsis, corticosteroid therapy) was found to be a significant risk factor. Because no data were available concerning chorioamnionitis, we could not test its relation with CLD.

    CONCLUSION

    Although the introduction of surfactant therapy has improved the survival rates of very preterm infants, COD incidence still remains high at 28 days of life. It decreases dramatically after 42 weeks' PCA, however. Its incidence is highest for the lowest GA survivors, a finding that emphasizes the importance of immaturity as the main pathogenic factor. This study, while confirming the previously reported risk factors and the variability of incidence among centers, underlines the importance of IUGR and initial illness severity as measured by CRIB score as strongly significant risk factors.

    ACKNOWLEDGMENTS

    We thank Serono Company, which provided pulse oximeters to each center for this study.

    Members of Collaborative Northern and Eastern France Study Group of Neonatal Intensive Care Units: B. Romeo, G. Krim (Amiens); J.Y. Pauchard, A. Menget (Besancon); B. Geneste, D. Semama, J.-B. Gouyon (Dijon); P. Truffert, A. Liska, P. Lequien (Lille); F. Cneude, P. Vittu (Lille St. Antoine); I Hamon, J.M. Hascoet (Nancy); L. Egreteau, P. Morville (Reims); J. Matis, U. Siméoni, J. Messer (Strasbourg).

    Footnotes

      • Received March 23, 2000.
      • Accepted March 28, 2001.
    • Reprint requests to (L.E.) American Memorial Hospital, 49 Rue Cognacq Jay, 51092 Reims Cedex, France. E-mail: legreteau{at}chu-reims.fr

    BPD =
    bronchopulmonary dysplasia •
    COD =
    chronic oxygen dependency •
    GA =
    gestational age •
    CLD =
    chronic lung disease •
    PCA =
    postconceptional age •
    CRIB =
    critical risk index for infants •
    IUGR =
    intrauterine growth restriction •
    RDS =
    respiratory distress syndrome

    REFERENCES

    1. ↵
      1. Halliday HL
      (1997) Clinical trials of surfactant replacement in Europe. Biol Neonate 71:8–12.
      OpenUrl
    2. ↵
      1. Millet V,
      2. Lacroze V,
      3. Bartoli JM,
      4. Samperiz S,
      5. Lelaire M,
      6. Unal D
      (1997) Pression positive continue précoce en salle de travail. Arch Pediatr 4:15–20.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      1. Cooke RW
      (1991) Factors associated with chronic lung disease in preterm infants. Arch Dis Child 66:776–779.
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Northway WH,
      2. Rosan RC,
      3. Porter DY
      (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276:357–368.
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      1. Bancalari E,
      2. Abdenour GE,
      3. Feller R,
      4. et al.
      (1979) Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95:819–823.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      1. Shennan AT,
      2. Dunn MS,
      3. Ohlsson A,
      4. Lennox K
      (1988) Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82:527–532.
      OpenUrlAbstract/FREE Full Text
    7. ↵
      1. The International Neonatal Network
      (1993) The CRIB (clinical risk index for babies) score: a tool assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 342:193–198.
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      1. Papile L,
      2. Burnstein J,
      3. Burnstein R,
      4. Koffler H
      (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 grams. J Pediatr 92:529–534.
      OpenUrlCrossRefPubMedWeb of Science
    9. ↵
      1. Lucas A,
      2. Cole TJ,
      3. Gandy GM
      (1986) Birthweight centiles in preterm infants. Early Hum Dev 13:313–322.
      OpenUrlCrossRefPubMedWeb of Science
    10. ↵
      1. Greenland S
      (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349.
      OpenUrlCrossRefPubMedWeb of Science
    11. ↵
      Truffert P, Rakza T, Liska A, Lequien P. Prématuritéextrême: les données de la littérature permettent elles de définir un pronostic? In: Treisser A, ed. 27e Journées Nationales de la Société Française de Médecine Périnatale. Paris, France: Arnette Blackwell; 1997:97–111
    12. ↵
      1. Menard MK
      (1998) Neonatal mortality for very low birth weight deliveries in South Carolina by level of hospital perinatal service. Am J Obstet Gynecol 179:374–381.
      OpenUrlCrossRefPubMedWeb of Science
    13. ↵
      1. Todd DA,
      2. Jana A,
      3. John E
      (1997) Chronic oxygen dependency in infants born at 24–32 weeks gestation: the role of antenatal and neonatal factors. J Paediatr Child Health 33:402–407.
      OpenUrlPubMedWeb of Science
    14. ↵
      1. Darlow BA,
      2. Horwood LJ
      (1992) Chronic lung disease in very low birthweight infants: a prospective population-based study. J Paediatr Child Health 28:301–305.
      OpenUrlPubMedWeb of Science
    15. ↵
      1. Fenton AC,
      2. Annich G,
      3. Mason E,
      4. et al.
      (1996) Chronic lung disease following neonatal ventilation. Incidence in two geographically defined populations. Pediatr Pulmonol 21:20–23.
      OpenUrlCrossRefPubMedWeb of Science
    16. ↵
      1. Avery ME,
      2. Tooley WH,
      3. Keller JB,
      4. et al.
      (1987) Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:26–30.
      OpenUrlAbstract/FREE Full Text
    17. ↵
      1. Lenoir S,
      2. Grandjean H,
      3. Leloup M,
      4. Claris O,
      5. Hascoet JM,
      6. le Groupe Osiris-France
      (1994) Short and mid-term outcome of 1157 neonates with respiratory distress syndrome. Arch Fr Pediatr 11:1004–1010.
      OpenUrl
    18. ↵
      1. Rubaltelli FF,
      2. Dani C,
      3. Reali MF,
      4. et al.
      (1998) Acute neonatal respiratory distress in Italy: a one-year prospective study. Acta Paediatr 87:1261–1268.
      OpenUrlCrossRefPubMedWeb of Science
    19. ↵
      1. Rautonen J,
      2. Mäkelä A,
      3. Boyd H,
      4. Apajasalo M,
      5. Pohjavuori M
      (1994) CRIB and SNAP: assessing the risk of death for preterm neonates. Lancet 343:1272–1273.
      OpenUrlCrossRefPubMedWeb of Science
    20. ↵
      1. Fowlie PW,
      2. Gould CR,
      3. Parry GJ,
      4. Philips G,
      5. Tarnow-Mordi WO,
      6. Strang D
      (1996) CRIB (clinical risk index for babies) in relation to nosocomial bacteraemia in very low birthweight or preterm infants. Arch Dis Child 75:F49–F52.
      OpenUrl
    21. ↵
      1. Fowlie PW,
      2. Gould CR,
      3. Tarnow-Mordi WO,
      4. Strang D
      (1998) Measurement properties of the clinical risk index for babies: reliability, validity beyond the first 12 hours, and responsiveness over 7 days. Crit Care Med 26:163–168.
      OpenUrlCrossRefPubMedWeb of Science
    22. ↵
      1. Marcin JP,
      2. Pollack MM
      (1998) Growth, development and aging of clinical risk index for babies. Crit Care Med 26:14.
      OpenUrlCrossRefPubMedWeb of Science
    23. ↵
      1. Mc Colley SA
      (1998) Bronchopulmonary dysplasia. Impact of surfactant therapy. Pediatr Clin North Am 43:573–586.
      OpenUrl
    24. ↵
      1. Le Guennec JC,
      2. Rufai M,
      3. Papageorgiou A
      (1993) Spectrum of oxygen dependency in surviving infants weighing 600 to 1000 grams: decreased incidence of severe chronic lung disease. Am J Perinatol 10:292–296.
      OpenUrlPubMedWeb of Science
    25. ↵
      1. Frank L,
      2. Lewis PL,
      3. Garcia-Pons T
      (1985) Intrauterine growth retarded rat pups show increased susceptibility to pulmonary oxygen toxicity. Pediatr Res 19:281–286.
      OpenUrlPubMedWeb of Science
    26. ↵
      1. Carlisle SC,
      2. Moxley MA,
      3. Longmore WJ
      (1987) Suppression of pulmonary surfactant secretion by starvation in rat fetal alveolar type II cells in primary culture [abstract]. Am Rev Respir Dis 135:A357.
      OpenUrl
    27. ↵
      Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infant. New York, NY: Oxford University Press; 1992:325–358
    28. ↵
      1. Groneck P,
      2. Speer CP
      (1995) Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 73:F1–F3.
      OpenUrlCrossRefWeb of Science
    29. ↵
      Groneck P, Gote-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluid of high risk preterm infants. Pediatrics. 1994;93:712–718
    • Copyright © 2001 American Academy of Pediatrics
    View Abstract
    PreviousNext

     

    Advertising Disclaimer »

    View this article with LENS
    PreviousNext
    Email

    Thank you for your interest in spreading the word on Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Chronic Oxygen Dependency in Infants Born at Less Than 32 Weeks' Gestation: Incidence and Risk Factors
    (Your Name) has sent you a message from Pediatrics
    (Your Name) thought you would like to see the Pediatrics web site.

    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Chronic Oxygen Dependency in Infants Born at Less Than 32 Weeks' Gestation: Incidence and Risk Factors
    Laurent Egreteau, Jean-Yves Pauchard, Denis S. Semama, Jacqueline Matis, Anne Liska, Bernard Romeo, Fabrice Cneude, Isabelle Hamon, Patrick Truffert
    Pediatrics Aug 2001, 108 (2) e26; DOI: 10.1542/peds.108.2.e26

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Chronic Oxygen Dependency in Infants Born at Less Than 32 Weeks' Gestation: Incidence and Risk Factors
    Laurent Egreteau, Jean-Yves Pauchard, Denis S. Semama, Jacqueline Matis, Anne Liska, Bernard Romeo, Fabrice Cneude, Isabelle Hamon, Patrick Truffert
    Pediatrics Aug 2001, 108 (2) e26; DOI: 10.1542/peds.108.2.e26
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Print
    PDF
    Insight Alerts
    • Table of Contents
    • Current Policy
    • Early Release
    • Current Issue
    • Past Issues
    • Editorial Board
    • Editorial Policies
    • Overview
    • Open Access
    • Pediatric Collections
    • Video Abstracts
    • Author Guidelines
    • Reviewer Guidelines
    • Submit My Manuscript

    Subjects

    • Fetus/Newborn Infant
      • Fetus/Newborn Infant
    Back to top

                

    Copyright (c) 2018 by American Academy of Pediatrics

    International Access »           

    Terms of Use
    Privacy Statement
    FAQ

    AAP Pediatrics